Karachi: The Searle Company Limited has scheduled a Board of Directors meeting for Friday, September 25, 2026, to deliberate on several key financial matters. The meeting will be held at the company's Karachi office and via videoconferencing.

In a notification dated September 18, 2026, the company announced its intention to review and approve both separate and consolidated audited financial statements for the fiscal year ending June 30, 2026. The agenda also includes discussions related to the declaration of any entitlements.

The company has enforced a "Closed Period" from September 19, 2026, to September 25, 2026, in compliance with clause 5.6.4 of the Rule Book of the Exchange. During this period, no director, CEO, or executive is permitted to engage in any share transactions of the company, directly or indirectly.

According to information available from the Pakistan Stock Exchange (PSX), these procedural announcements are part of the regulatory framework to ensure transparency and fairness in the market. The Searle Company Limited operates within the pharmaceutical sector, contributing to the designated market category of healthcare and pharmaceuticals.

The company has advised TRE Certificate holders of the Exchange to take note of these developments.